COMMUNIQUÉS West-GlobeNewswire

Letter to Shareholders to accompany recent proxy filing
16/11/2018
CEO to share a few thoughts in advance of the upcoming shareholder call on Monday, November 19 th at 5PM EST NEW HAVEN, Conn., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: [...]
Flexion Therapeutics Named Top Place to Work for Second Consecutive Year by The Boston Globe
16/11/2018
BURLINGTON, Mass., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has been named one of the Top Places to Work in Massachusetts for the second consecutive year. The [...]
New Findings Presented at the VEITHsymposium Reiterate Consistent, Durable Outcomes in Complex Aortic Disease with Heli-FX(TM) Endoanchor(TM) System
16/11/2018
Three-Year Data from the ANCHOR Registry Reiterate Applicability in Patients with Hostile Aortic Neck Anatomies DUBLIN and NEW YORK - November 16, 2018 - Medtronic plc (NYSE:MDT) today announced new data on the Heli-FX( [...]
ATW Tech Provides Additional Information Regarding Signature of a Letter of Intent for Major Acquisition of Greywolf Entertainment Group
16/11/2018
MONTREAL, Nov. 16, 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (“ ATW Tech ”) (TSX-V: ATW) has, as previously announced on November 6, 2018, signed a letter of intent for the acquisition from Fastrack Trust (the “ Trust ”) [...]
ATW Tech fournit de l’information additionnelle sur la signature de la lettre d’intention pour l’acquisition majeure du Groupe Greywolf Entertainement
16/11/2018
MONTRÉAL, 16 nov. 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (« ATW Tech ») ( TSX-V : ATW ), a signé, tel qu’annoncé le 6 novembre 2018, une lettre d’intention visant l’acquisition de la totalité des actions de 6855318 [...]
Lifestyle Brand Weekend Unlimited Expanding Into Key US, Foreign Markets -- CFN Media
16/11/2018
SEATTLE, Nov. 16, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Menlo Therapeutics to Participate in the 30th Annual Piper Jaffray Healthcare Conference
16/11/2018
REDWOOD CITY, Calif., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus associated [...]
Aurora Spine Announces Exclusive Patent License Agreement for MIS SI Joint Product
16/11/2018
CARLSBAD, Calif., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (TSXV:ASG) ("Aurora Spine" or the "Company") announced today that it has acquired an exclusive license to US patent #9,451,986 titled “ [...]
Dragon Jade Announces Filing of Registration Statement for Proposed Registered Offering
16/11/2018
HONG KONG, Nov. 16, 2018 (GLOBE NEWSWIRE) -- Dragon Jade International Limited (“Dragon Jade” or “the Company”) (OTCQX: DGJI), a provider of premier products and services, today notes that it has filed a registration [...]
Novartis receives positive CHMP opinion to expand Kisqali® combination therapy to all women with HR+/HER2- locally advanced or metastatic breast cancer
16/11/2018
Kisqali is the CDK4/6 inhibitor with the largest body of first-line evidence demonstrating consistent, superior and sustained efficacy vs. endocrine therapy alone[1] CHMP opinion is supported by two pivotal Phase III [...]
Progressive Care Inc. Announces Record-Breaking October 2018
16/11/2018
MIAMI, Nov. 16, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and record-breaking [...]
Neon Therapeutics Named a Top Place to Work in Massachusetts by The Boston Globe
16/11/2018
CAMBRIDGE, Mass., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics (Nasdaq: NTGN) has been named one of the top places to work in Massachusetts by The Boston Globe , an honor awarded based on employee feedback. The [...]
Imprimis Pharmaceuticals Ranked 88th Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500™
16/11/2018
Imprimis attributes growth to its vision of making sure patients have access to high quality affordable medications SAN DIEGO, Nov. 16, 2018 (GLOBE NEWSWIRE) -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) today [...]
Stemline Therapeutics Announces Oral Presentation of SL-701 Phase 2 Data in Second-Line Glioblastoma at the 23rd Annual Meeting of the Society of Neuro-Oncology (SNO)
16/11/2018
NEW YORK, Nov. 16, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a biopharmaceutical company focused on the development and potential commercialization of novel oncology therapeutics, announced [...]
Sanofi: European Medicines Agency recommends fexinidazole, the first all-oral treatment for sleeping sickness
16/11/2018
European Medicines Agency recommends fexinidazole, the first all-oral treatment for sleeping sickness The positive opinion is the result of a 10-year partnership between the Drugs for Neglected Diseases initiative (DND [...]
Sanofi : L'Agence européenne des médicaments recommande l'approbation du fexinidazole, le premier traitement entièrement par voie orale de la maladie du sommeil
16/11/2018
L'Agence européenne des médicaments recommande l'approbation du fexinidazole, le premier traitement entièrement par voie orale de la maladie du sommeil L'avis favorable de l'EMA est l'aboutissement d'une collaboration [...]
BeiGene Announces Preliminary Clinical Data on PARP Inhibitor Pamiparib Presented at Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology
16/11/2018
CAMBRIDGE, Mass., and BEIJING, China, Nov. 16, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
BioCryst Presents Data Highlighting the Rapid and Sustained Plasma Concentrations of BCX7353 in HAE Patients at the Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology
16/11/2018
RESEARCH TRIANGLE PARK, N.C., Nov. 16, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today presented data showing that an oral formulation of BCX7353 was rapidly absorbed and exhibited a long [...]
Agios Presents Updated Data from Phase 1 Dose-Escalation Study of AG-881 in Patients with IDH Mutant Positive Advanced Glioma
16/11/2018
– Median Treatment Duration of 15 Months Observed in Non-Enhancing Glioma with 13 Patients Remaining on Treatment Provides Evidence of Prolonged Disease Control – – Favorable Safety Profile at 10 mg and 50 mg, Doses [...]

Pages